IncobotulinumtoxinA Drug Interactions
Currently displaying a list of 120 drugs known to interact with incobotulinumtoxinA.
- 25 major drug interactions
- 95 moderate drug interactions
Medications known to interact with incobotulinumtoxinA
Note: Showing generic names only.
A
- abobotulinumtoxinA
- acrivastine
- amikacin
- amikacin liposome
- amitriptyline
- amoxapine
- atracurium
- atropine
- azatadine
B
C
- carbinoxamine
- carisoprodol
- chlorcyclizine
- chlorphenesin
- chlorpheniramine
- chlorpromazine
- chlorzoxazone
- cisatracurium
- clemastine
- clidinium
- clomipramine
- clozapine
- colistimethate
- cyclizine
- cyclobenzaprine
- cyproheptadine
D
- dantrolene
- darifenacin
- daxibotulinumtoxinA
- desipramine
- dexbrompheniramine
- dexchlorpheniramine
- dicyclomine
- dimenhydrinate
- diphenhydramine
- disopyramide
- doxacurium
- doxepin
- doxepin topical
- doxylamine
F
G
H
I
K
L
M
- maprotiline
- meclizine
- mepenzolate
- mesoridazine
- metaxalone
- methdilazine
- methocarbamol
- methotrimeprazine
- methscopolamine
- metocurine
- mivacurium
- molindone
N
O
P
- pancuronium
- paromomycin
- perphenazine
- phenindamine
- pimozide
- pipecuronium
- plazomicin
- polymyxin b
- prabotulinumtoxinA
- prochlorperazine
- procyclidine
- promazine
- promethazine
- propantheline
- propiomazine
- protriptyline
- pyrilamine
Q
R
S
T
- thiethylperazine
- thioridazine
- thiothixene
- tiotropium
- tizanidine
- tobramycin
- tolterodine
- trifluoperazine
- triflupromazine
- trihexyphenidyl
- trimeprazine
- trimipramine
- tripelennamine
- triprolidine
- trospium
- tubocurarine
V
IncobotulinumtoxinA disease interactions
There are 3 disease interactions with incobotulinumtoxinA which include:
Report options
QR code containing a link to this page
More about incobotulinumtoxinA
- incobotulinumtoxinA consumer information
- Check interactions
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: skeletal muscle relaxants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
